What Are the Key Opportunities in India’s Fertility Healthcare Segment?

 2 in 12 couples are facing infertility- related concerns in their life in India. There are various options available to couples, such as Fertility medications (Oral and Injectables), surgical treatments, and assisted reproductive technologies. For infertility management, women are seeking minimally invasive fertility treatments, including fertility drugs. 


Adorefem is a Top Fertility Medicine and Gynaecology Pharma company in India, superspecialised in gynaecology, pro-fertility, and IVF treatment. Its product offerings, covering various dosage forms and therapeutic segments, make it an attractive option for pharmaceutical businesses dedicated to catering to women with fertility-related issues.

Fertility Healthcare Market Size in 2026

The fertility Drug Market size is projected to be valued at around USD 3 billion in 2026, according to Fortune Business Insights. 

The expansion in the Fertility Healthcare Market size could be seen for the following reasons:


Rise of Digital Pharmacies: The Indian healthcare ecosystem and e-pharmacy infrastructure are stronger now, making fertility medicines more accessible to the population, also covering Tier-II and Tier-III cities

Better IVF services: The IVF Treatment centres are growing in number, making people more aware of fertility treatments, and fertility drugs often support these treatments in various stages.

Fertility support products: Along with fertility drugs, the market includes reproductive nutritional support products, helping businesses expand their product portfolios and catering to customised treatment plans of people.


Opportunities to Tap into India’s Fertility Healthcare Segment

Businesses Interested in investing in the fertility healthcare segment can explore different product categories such as IVF and fertility range, PCOS management, hormonal support, reproductive nutritional support, along with Male fertility.



  • Rising demand for fertility care products: Women are becoming aware of the preventive measures if they want to conceive naturally, leading to an increase in demand for such products.

  • High PCOS-related issues: PCOS may or may not become a reason for infertility, but it is often associated with it. PCOS management is an emerging segment that is beneficial to invest in.

  • Supports Assisted Reproductive Treatment: Various Fertility medicines act as support in ART, such as IVF treatments, often being prescribed to patients undergoing such treatments.

  • Availability of varied dosage forms: Fertility care products are available in various formats such as tablets, injectables, syrups and more and providing women to choose a form as per their preference.


Why choose Adorefem as your fertility Healthcare Product Partner?

Adorefem is a top Gynecology and fertility Medicine company in India. It offers quality-assured gynecology and fertility medicine at competitive pricing with reasonable Minimum order Quantities.


Certifications: Adorefem offers only those fertility healthcare products that are approved by DCGI and It holds certifications from WHO-cGMP and ISO. Its products adhere to all the international critical quality standards, making them suitable for international markets.

Extensive Fertility product range: Adorefem’s product offerings include wide range of forms such as Tablets, Soft gel capsules, Sachets, Oral liquids and syrups, Topical gel and Injectables. The therapeutic areas it covers are IVF and fertility range (Male and Female), PCOS Management, Pregnancy care and Prenatal supplements, Menstrual and Endometrial Health and Menopause care.

Superspeciality: The superspeciality of Adorefem is Women’s Reproductive Healthcare that covers Obstetrics, Gynaecology, Pro-fertility and IVF Treatment range.

After-Sales support: Adorefem Provides Marketing and Branding support to its clients in the form of physical marketing tools such as customised bags, notepads, etc and marketing support via their campaigns related to women healthcare awareness. 


Product offerings by Adorefem in the Fertility Healthcare Segment

Adorefem has been a well-known pharmaceutical company since 2009 and offers Gynaecology products in India in the following categories:

  • Female fertility and Ovulation support

  • Male Fertility and Reproductive health

  • PCOS & Metabolic fertility support

  • Hormonal and IVF-Related support

  • Sexual and Reproductive health.


The Product compositions offered by Adorefem in the above categories are as follows:


  • L-Citrulline 250 mg and  L-Arginine 750 mg 

  • Dienogest 2 mg

  • Astaxanthin 16 mg and  Coenzyme Q10 200 mg

  • Astaxanthin and Ferrous Gluconate and Zinc Oxide and L-Arginine + Pyridoxine HCl and Lycopene and Folic Acid and L-Selenomethionine

  • Coenzyme Q10 100 mg and Ashwagandha Extract 150 mg and  L-Carnitine 500 mg and  Zinc Oxide 12 mg and Lycopene 4 mg and L-Methylfolate 0.8 mg and Sodium Selenate 0.04 mg

  • Tripterygium Wilfordii Root Extract 20 mg and  Green Tea Extract (EGCG) 400 mg and  Vitamin D3 1,000 IU

  • Mifepristone 10 mg

  • Clomiphene Citrate and Melatonin



Conclusion

Infertility is growing in India due to various reasons such as a sedentary lifestyle, a highly processed diet, high levels of stress, and PCOS issues. Fertility Medicine is an attractive option among people because to its accessibility. Adorefem is a dominant gynaecology and fertility medicine company offering quality-assured products with marketing and branding support.



Comments

Popular posts from this blog

How Adorefem is Revolutionizing Fertility Product Exports

How Adorefem Ensures Competitive Pricing Without Compromising Quality

How to Launch Your Nutraceutical Business with Coral Calcium + D3 Products